In Turkey, the population-based frequency of gastroesophageal reflux disease (GERD) is between 19% and 25%. This high-burden disease is seen in approximately 1 in every 4-5 adults. There are some characteristic features of this disease in Turkey. In the first installment of this two-part consensus report, we describe classical GERD. Later, we will examine GERD-related extra-esophageal findings and review indications for endoscopic treatment and surgery.
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In 2014, physicians prescribed 81 million boxes of gastric medications in general and 51 million boxes of proton pump inhibitors (PPIs) in Turkey. Approximately 750 millions Turkish Lira (about 175 millions Euro) was overspent for these medications. PPIs are the most important medications for treating GERD; however, they should be used with careful attention given to dosage and treatment duration. In Turkey, guidelines are needed for the first-, second-, and third-line healthcare approaches for patients with GERD, most of whom have non-erosive reflux. 6) Although it is the topic for the next consensus report, the similar problems are encountered while examining atypical symptoms of reflux, may be more seriously. It is necessary to establish a joint diagnostic and treatment plan, with contributions from otorhinolaryngology and chest disease specialists. 7) Recent years have seen increases in the number of surgical interventions for GERD. We require a consensus regarding surgical indications. 8) GERD medications that are safe for use during pregnancy and lactation should be established. 9) Beliefs pertaining to side effects of PPIs, which are not based on scientific evidence, are common. Strong scientific evidence is needed to inform patients and healthcare practitioners.
Based on these reasons we established nine study groups, each consisting of two people, including specialists and assistant researchers. When considered from an international perspective, we are hopeful that this consensus report can stand as an example for non-Western countries where the frequency of Helicobacter pylori infection is high, the prevalence of Barrett's esophagus is low, and the Caucasian race is dominant.
Study Groups and Questions
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